Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

ANALYSIS OF THE KIR GENES IMPACT ON HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOME ACCORDING TO THREE DIFFERENT PREDICTIVE MODELS FROM LITERATURE (CROSBI ID 684204)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Burek Kamenarić, Marija ; Štingl Janković, Katarina ; Grubić, Zorana ; Maskalan, Marija ; Serventi Seiwerth, Ranka ; Mikulić, Mirta ; Žunec, Renata ANALYSIS OF THE KIR GENES IMPACT ON HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOME ACCORDING TO THREE DIFFERENT PREDICTIVE MODELS FROM LITERATURE // HLA / Marsh, Steven GE (ur.). 2018. str. 404-405 doi: 10.1111/tan.13251

Podaci o odgovornosti

Burek Kamenarić, Marija ; Štingl Janković, Katarina ; Grubić, Zorana ; Maskalan, Marija ; Serventi Seiwerth, Ranka ; Mikulić, Mirta ; Žunec, Renata

engleski

ANALYSIS OF THE KIR GENES IMPACT ON HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOME ACCORDING TO THREE DIFFERENT PREDICTIVE MODELS FROM LITERATURE

One of the many factors influencing hematopoietic stem cell transplantation (HSCT) is the presence of donor- derived alloreactive NK cells that are formed mainly as the result of KIR-HLA ligand mismatching. Three models for predicting alloreactive NK cell formation exist: the ligand- ligand model, KIR receptor-ligand model and KIR haplotype model. The purpose of this study was to analyze the association of patient and donor KIR ligands, KIR genes and genotypes on HSCT outcome and to see which of the three models the best algorithm to predict HSCT outcomes is. The investigated group consisted of 56 patient-donor pairs that had undergone unrelated HSCT in University Hospital Centre Zagreb. Analysis according to the ligandligand model in the studied group resulted in only four mismatches as opposed to the KIR-ligand model where 31 patient-donor pairs were KIR-ligand mismatched, leading to the conclusion that determining KIR ligand mismatches only following patient-donor HLA typing, without KIR genotyping of donors, is not good prognostic algorithm. The inhibitory KIR-HLA ligand matches/mismatches determined with the KIR-ligand model did not show any beneficial effect of KIR ligand mismatches on any investigated HSCT endpoint. Assigning the AA or Bx KIR genotype to each patient and donor (patient/donor combinations: AA/AA, AA/Bx, Bx/AA and Bx/Bx) enabled its analysis according to the third model and, although no statistically significant difference was found, a trend towards better survival was observed in AA patients receiving a Bx graft. The conclusion is that any of existing models to predict alloreactive NK cell formation and their effect on HSCT outcomes can't give the answer alone and to clarify the KIR influence on HSCT outcome, different approaches in the analyses which encompasses all properties of KIR genes/receptors, KIR-ligands and NK cells together needs to be taken into consideration.

KIR genes, HSCT

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

404-405.

2018.

nije evidentirano

objavljeno

10.1111/tan.13251

Podaci o matičnoj publikaciji

HLA

Marsh, Steven GE

2059-2310

Podaci o skupu

32nd European Immunogenetics and Histocompatibility Conference (EFI) ; 25th Annual Meeting of the Italian Society for Immunogenetics and Transplantation Biology (AIBT)

poster

09.05.2018-12.05.2018

Venecija, Italija; Lido, Italija

Povezanost rada

Biologija, Kliničke medicinske znanosti

Poveznice
Indeksiranost